Trial Profile
Effects of olmesartan medoxomil on renal function and ambulatory blood pressure in hypertensive patients with chronic kidney disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Aug 2013
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Antihypertensives
- Indications Hypertension
- Focus Pharmacodynamics; Therapeutic Use
- 21 Nov 2012 New trial record
- 04 Oct 2012 Results presented at the 24th Scientific Meeting of the International Society of Hypertension.